Brief: Theratechnologies Reports Results From Trogarzo IV Push Administration Study at CROI 2022
Feb 16 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES PRESENTS RESULTS FROM TROGARZO® IV PUSH
ADMINISTRATION STUDY AT CROI 2022
* THERATECHNOLOGIES INC - NO DIFFERENCE IN VIRAL LOAD
BETWEEN IV
PUSH AND IV INFUSION AND NO ANTI-DRUG ANTIBODIES DETECTED
Source text for Eikon: ID:nGNX6TC9Xr
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process